AI Drug Startup Soars, But the Real Story is a VC’s Redemption
Shares of AI drug discovery firm Insilico surged in their Hong Kong debut. Meanwhile, the acquisition of AI agent startup Manus appears to have delivered a huge win for Benchmark Capital, a firm many had written off.